Highlights in metastatic kidney cancer research from the 2023 International Kidney Cancer Symposium include promising data on zanzalintinib, a dose-finding study on belzutifan, and further ...

In total, 169 patients participated in the survey; the majority of the patients stated their general health status as good (72.2%) and excellent (13.6%). Patients who rated their overall health status ...

CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer. For patients with metastatic kidney cancer, a multidisciplinary approach ...

The distinction between feeling "cured" and "consumed" by cancer significantly impacts patients' stress levels and daily ...

Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney ...

A majority of patients with non-locally treated brain metastases from kidney cancer remained free of metastatic progression for at least 6 months when treated with cabozantinib (Cabometyx), a small ...

Temporal patterns in renal cancer mortality: A 20-year analysis of US-Mexico border states. Cytoreductive nephrectomy for patients with metastatic non-clear cell renal cell carcinoma: Results from a ...

Please provide your email address to receive an email when new articles are posted on . Changing the gut microbiome improved objective response rate among patients with metastatic kidney cancer. The ...

OPTIC-RCC trial used RNA sequencing to identify angiogenic tumors, showing improved outcomes with cabozantinib and nivolumab, ...

UCLA researchers have developed a new kind of immunotherapy that uses specially engineered immune cells equipped with built-in weapons to attack kidney cancer tumors and reprogram their protective ...